| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Metabolic Syndrome | D024821 | 44 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
| Scholtysek C et al. | PPARβ/δ governs Wnt signaling and bone turnover. | 2013 | Nat. Med. | pmid:23542786 |
| Stuss M et al. | Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23543663 |
| Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
| Løgstrup BB et al. | Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. | 2013 | Coron. Artery Dis. | pmid:23777975 |
| Zhang Y et al. | Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. | 2013 | Clinics (Sao Paulo) | pmid:23778340 |
| Pichler K et al. | Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. | 2013 | Connect. Tissue Res. | pmid:23941205 |
| Fontes JD et al. | Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. | 2013 | Atherosclerosis | pmid:23489346 |
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Wei CC et al. | Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. | 2013 | BMC Complement Altern Med | pmid:23870279 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Cao H et al. | Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. | 2013 | Ann. Thorac. Surg. | pmid:23870696 |
| Xu F et al. | Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. | 2013 | Mol Med Rep | pmid:23835909 |
| Zhu J et al. | The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. | 2013 | Genet Test Mol Biomarkers | pmid:23837846 |
| Di Bartolo BA et al. | TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL. | 2013 | PLoS ONE | pmid:24040204 |
| Zong ming W et al. | Bone formation in rabbit cancellous bone explant culture model is enhanced by mechanical load. | 2013 | Biomed Eng Online | pmid:23597232 |
| Napimoga MH et al. | Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. | 2013 | Int. Immunopharmacol. | pmid:23597428 |
| Liu CG et al. | [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:24517065 |
| Wang Q et al. | [Effects of treadmill exercise on mRNA expression levels of osteoprotegerin, RANKL and RUNX2 in bone tissues of ovariectomized]. | 2013 | Zhongguo Gu Shang | pmid:24605748 |
| Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
| Matsuo K | [Osteoimmunologic regulation of aging]. | 2013 | Clin Calcium | pmid:23268303 |
| Wang X et al. | Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. | 2013 | Chin. J. Traumatol. | pmid:24103822 |
| Chen X et al. | Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. | 2013 | Food Chem. Toxicol. | pmid:23954550 |
| Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
| Malik P et al. | Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. | 2013 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:23380173 |
| Pereira GB et al. | Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome. | 2013 | Clin Physiol Funct Imaging | pmid:23383690 |
| Grant M et al. | Induction of cytokines, MMP9, TIMPs, RANKL and OPG during orthodontic tooth movement. | 2013 | Eur J Orthod | pmid:22987319 |
| Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
| Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
| Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
| Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
| Boumans MJ et al. | Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. | 2012 | Ann. Rheum. Dis. | pmid:22072013 |
| Chen X et al. | Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. | 2012 | Biol Trace Elem Res | pmid:22076734 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Robinson DE et al. | Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. | 2012 | Biomaterials | pmid:22079008 |
| Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
| Aliprantis AO et al. | Transient muscle paralysis degrades bone via rapid osteoclastogenesis. | 2012 | FASEB J. | pmid:22125315 |
| Ueland T et al. | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. | 2012 | Curr Heart Fail Rep | pmid:22453763 |
| Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
| Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
| Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
| Liu L et al. | Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. | 2012 | J Endod | pmid:22703658 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Zupan J et al. | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. | 2012 | J. Biomed. Sci. | pmid:22380539 |
| Santos VR et al. | Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. | 2012 | J. Periodont. Res. | pmid:21806617 |
| Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
| Hudson JB et al. | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. | 2012 | Calcif. Tissue Int. | pmid:22382900 |
| Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
| Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
| Eleftheriadis T et al. | Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. | 2012 | Iran J Kidney Dis | pmid:22388612 |
| Heymann MF et al. | Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. | 2012 | Cytokine | pmid:22402034 |
| Sun C et al. | [Acqusition of full-length gene for rabbit osteoprotegerin]. | 2012 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:22404020 |
| Oelzner P et al. | The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. | 2012 | Rheumatol. Int. | pmid:20821212 |
| Fossmark R et al. | Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. | 2012 | J. Cell. Biochem. | pmid:21882222 |
| Oka H et al. | Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. | 2012 | J. Periodontol. | pmid:21910594 |
| Wang JQ et al. | [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. | 2012 | Zhongguo Gu Shang | pmid:23427595 |
| Altan BA et al. | Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. | 2012 | Lasers Med Sci | pmid:21038101 |
| Singh PP et al. | Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22561018 |
| Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
| Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Kam WW et al. | The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. | 2012 | PLoS ONE | pmid:22295097 |
| Martin CK et al. | Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. | 2012 | Oral Oncol. | pmid:22265717 |
| Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
| Garlet GP et al. | Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. | 2012 | J Endod | pmid:22244633 |
| Rimondi E et al. | Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. | 2012 | Invest New Drugs | pmid:21541705 |
| Makras P et al. | Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. | 2012 | J. Clin. Endocrinol. Metab. | pmid:22278426 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Cauley JA | Commentary: A single biomarker in a complex metabolic pathway. | 2012 | Int J Epidemiol | pmid:22933649 |
| Deuell KA et al. | RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. | 2012 | J. Vasc. Res. | pmid:22948607 |
| Li F et al. | Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. | 2012 | Fitoterapia | pmid:22951288 |
| Buckle CH et al. | Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. | 2012 | PLoS ONE | pmid:22952578 |
| Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
| Zhao N et al. | Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22196183 |
| Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
| Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
| Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
| Wang S and Liu YS | [Advance on arterial calcification]. | 2012 | Sheng Li Ke Xue Jin Zhan | pmid:23189619 |
| Rashtchizadeh N et al. | Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. | 2012 | Ther Apher Dial | pmid:23190522 |
| Pecchi E et al. | A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. | 2012 | Osteoarthr. Cartil. | pmid:22179028 |
| Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
| Nyrnes A et al. | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. | 2012 | Gend Med | pmid:23046763 |
| Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
| Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
| Kleyer A et al. | Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. | 2012 | J. Bone Miner. Res. | pmid:22806960 |
| Giaginis C et al. | Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. | 2012 | Med. Sci. Monit. | pmid:23018352 |
| Wang C et al. | Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. | 2012 | J. Bone Miner. Res. | pmid:22807154 |
| Poerschke RL et al. | Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012 | J. Biochem. Mol. Toxicol. | pmid:22807314 |
| Chandran V | Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. | 2012 | J Rheumatol Suppl | pmid:22751596 |
| Melchiorre D et al. | RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. | 2012 | J. Rheumatol. | pmid:22753650 |
| Tenta R et al. | Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. | 2012 | J. Endocrinol. Invest. | pmid:21606670 |
| Zhou W and Mei L | Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. | 2012 | Int J Periodontics Restorative Dent | pmid:22754911 |